Amorepacific held a symposium in New York on October 13 (local time) focused on “Skin Longevity,” where it presented clinical evidence for proprietary ingredients validated through collaborative research with Johns Hopkins University School of Medicine, the company said on October 14.
Since 2022, Amorepacific and Johns Hopkins Dermatology have run the Nature-Based Research Initiative (NBRI) to investigate mechanisms of skin longevity. At the symposium, Amorepacific detailed the mechanisms and clinical benefits of three core ingredients—Ginsenomics, Lymphanax and Red Flavonoid—highlighting their roles in delaying skin aging and maintaining healthy skin.
In the keynote, Johns Hopkins professor Se‑won Kang emphasized skin as a valuable model for human aging research, noting that cellular changes in skin mirror aging processes in other organs. He said skin can serve as a biomarker for systemic inflammatory signaling and urged expanding the concept of “skin longevity” beyond aesthetics to a marker of overall healthy aging.
Park Won‑seok, director of Amorepacific’s R&I Center, reported that combined analyses of photoaging and complex aging processes confirmed inflammation accelerates skin aging. He explained that Ginsenomics™, Amorepacific’s core anti‑aging ingredient, suppresses inflammatory responses in skin and prevents oxytalan fiber degradation, thereby protecting dermal structure. Ginsenomics is produced by concentrating trace active components from ginseng 6,000‑fold and applying a technology to maximize skin absorption.
Johns Hopkins’ Martin Prince Alphonse and Amorepacific researchers shared findings that ginseng root extracts have anti‑inflammatory and immunomodulatory effects. They reported the ingredient helps correct immune imbalance caused by external stressors and supports healthy skin aging through age‑related immune regulation.
Professor Anna Chien presented anti‑aging effects of camellia seed extract, demonstrating its ability to restore function in aged skin cells and promote collagen production, improving skin firmness and thickness. In a 24‑week clinical trial of 44 participants using 0.1% camellia seed extract, researchers observed overall improvements in wrinkles, skin texture, radiance and pigmentation, with radiance improvements appearing as early as eight weeks.
Jung Hye‑jin, executive vice president of Amorepacific’s Sulwhasoo brand, said the scientific validation of Amorepacific’s skin‑longevity ingredients through joint research with Johns Hopkins is highly meaningful.
